The Canadian Methotrexate and Etanercept Outcome Study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis

OBJECTIVE: To determine if withdrawing methotrexate (MTX) after 6 months of combination etanercept (ETN)+MTX, in MTX-inadequate responders with active rheumatoid arthritis (RA), is non-inferior to continuing ETN+MTX. METHODS: Tumour necrosis factor-inhibitor naïve RA patients with disease activity s...

Descripción completa

Detalles Bibliográficos
Autores principales: Pope, Janet E, Haraoui, Boulos, Thorne, J Carter, Vieira, Andrew, Poulin-Costello, Melanie, Keystone, Edward C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251190/
https://www.ncbi.nlm.nih.gov/pubmed/23979914
http://dx.doi.org/10.1136/annrheumdis-2013-203684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251190/
https://www.ncbi.nlm.nih.gov/pubmed/23979914
http://dx.doi.org/10.1136/annrheumdis-2013-203684

Ejemplares similares